SHANGHAI – Chinese drugmakers are building factories to produce mRNA vaccines like Western vaccines that have proven effective against COVID-19. There’s a problem: plans probably won’t be in place when the plants are finished.
CanSino Biologics is scheduled for the full structure of a plant in Shanghai in late November. The biotech startup’s project, which earned more than one billion yuan ($139 million) in investment, covers an area of 17,000 square meters that will occupy 3 buildings. , according to the local government.